Lifekyor Overseas Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 4.45%
(FY 2023)
- Ebitda 33.33%
(FY 2023)
- Net Worth -1.46%
(FY 2023)
- Total Assets -28.28%
(FY 2023)
About Lifekyor Overseas
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagbir Singh, Jagdish Hirani, Rushikumarkanaiyalal Ribadiya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24111GJ2017PTC099549
- Company No.
099549
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lifekyor Overseas?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagbir Singh  | Director | 20-Oct-2017 | Current |
| Jagdish Hirani | Director | 20-Oct-2017 | Current |
| Rushikumarkanaiyalal Ribadiya | Director | 20-Oct-2017 | Current |
| Namankumar Trapsia | Director | 20-Oct-2017 | Current |
| Manubhai Jiyani | Director | 20-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Lifekyor Overseas.
Lifekyor Overseas Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 4.45% increase in profit. The company's net worth dipped by a decrease of 1.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifekyor Overseas?
In 2023, Lifekyor Overseas had a promoter holding of 86.00% and a public holding of 14.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Axter Pharmaceuticals Private LimitedActive 10 years 3 monthsJagdish Hirani and Rushikumarkanaiyalal Ribadiya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lifekyor Overseas?
Unlock and access historical data on people associated with Lifekyor Overseas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifekyor Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifekyor Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
